AU8950291A - Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging - Google Patents
Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imagingInfo
- Publication number
- AU8950291A AU8950291A AU89502/91A AU8950291A AU8950291A AU 8950291 A AU8950291 A AU 8950291A AU 89502/91 A AU89502/91 A AU 89502/91A AU 8950291 A AU8950291 A AU 8950291A AU 8950291 A AU8950291 A AU 8950291A
- Authority
- AU
- Australia
- Prior art keywords
- deferoxamine
- polymer
- magnetic resonance
- resonance imaging
- ferric iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
- A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Signal Processing (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59804490A | 1990-10-16 | 1990-10-16 | |
US598044 | 1990-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8950291A true AU8950291A (en) | 1992-05-20 |
Family
ID=24393999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU89502/91A Abandoned AU8950291A (en) | 1990-10-16 | 1991-10-15 | Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0553273A4 (en) |
JP (1) | JPH06502177A (en) |
AU (1) | AU8950291A (en) |
CA (1) | CA2094028A1 (en) |
WO (1) | WO1992007259A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU673153B2 (en) * | 1992-01-15 | 1996-10-31 | University Of Washington | A method for estimating the biologic potential of a selected carcinoma in a patient |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
US5707604A (en) * | 1986-11-18 | 1998-01-13 | Access Pharmaceuticals, Inc. | Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
US5688488A (en) * | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
US5494030A (en) * | 1993-08-12 | 1996-02-27 | Trustees Of Dartmouth College | Apparatus and methodology for determining oxygen in biological systems |
US6106866A (en) * | 1995-07-31 | 2000-08-22 | Access Pharmaceuticals, Inc. | In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites |
AT409929B (en) * | 1997-03-07 | 2002-12-27 | Tritthart Helmut A Dr | Infusion solution containing inert macromolecule becoming preferentially enriched in tumor-associated neovascularization regions, useful as carrier and targeting agent in tumor diagnosis and therapy |
DE19808079A1 (en) * | 1998-02-20 | 1999-08-26 | Schering Ag | New hydroxyethyl starch conjugates useful as X-ray, NMR and blood-pool diagnostic agents, e.g. for diagnosis of tumors, cardiovascular disorders and inflammation |
IL127621A (en) * | 1998-12-17 | 2002-05-23 | Yissum Res Dev Co | Method for measuring non-bound metal in serum and biological fluids |
WO2002094271A1 (en) * | 2001-05-15 | 2002-11-28 | Faulk Pharmaceuticals, Inc. | Targeted delivery of bioaffecting compounds for the treatment of cancer |
US6961607B2 (en) | 2002-07-31 | 2005-11-01 | Uzgiris Egidijus E | Method for assessing myocardial angiogenesis |
US20040024317A1 (en) * | 2002-07-31 | 2004-02-05 | Uzgiris Egidijus E. | Method for assessing capillary permeability |
PT1585548T (en) * | 2002-12-09 | 2018-10-17 | Abraxis Bioscience Llc | Compositions and methods of delivery of pharmacological agents |
CN103405405A (en) * | 2002-12-09 | 2013-11-27 | 阿布拉西斯生物科学有限责任公司 | Compositions and methods of delivery of pharmacological agents |
CN114460163B (en) * | 2022-02-11 | 2023-03-03 | 河北师范大学 | MALDI mass spectrometry imaging method for detecting iron content of biological tissue |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56125317A (en) * | 1980-03-08 | 1981-10-01 | Nippon Mejifuijitsukusu Kk | Stable radioactive diagnosticum with radioactive metallic mark |
US4666697A (en) * | 1982-12-08 | 1987-05-19 | Nihon Medi-Physics Co., Ltd. | Radioactive diagnostic agent |
US4863964A (en) * | 1985-07-02 | 1989-09-05 | Biomedical Frontiers, Inc. | Method for the stabilization of deferoxamine to chelate free ions in physiological fluid |
GB8610551D0 (en) * | 1986-04-30 | 1986-06-04 | Hoffmann La Roche | Polypeptide & protein derivatives |
US4999445A (en) * | 1988-06-10 | 1991-03-12 | The Regents Of The University Of California | Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system |
-
1991
- 1991-10-15 WO PCT/US1991/007546 patent/WO1992007259A1/en not_active Application Discontinuation
- 1991-10-15 EP EP91920236A patent/EP0553273A4/en not_active Withdrawn
- 1991-10-15 JP JP4500706A patent/JPH06502177A/en active Pending
- 1991-10-15 AU AU89502/91A patent/AU8950291A/en not_active Abandoned
- 1991-10-15 CA CA 2094028 patent/CA2094028A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU673153B2 (en) * | 1992-01-15 | 1996-10-31 | University Of Washington | A method for estimating the biologic potential of a selected carcinoma in a patient |
Also Published As
Publication number | Publication date |
---|---|
EP0553273A1 (en) | 1993-08-04 |
WO1992007259A1 (en) | 1992-04-30 |
JPH06502177A (en) | 1994-03-10 |
EP0553273A4 (en) | 1998-04-22 |
CA2094028A1 (en) | 1992-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0465068A3 (en) | Switched field magnetic resonance imaging | |
EP0412695A3 (en) | Magnetic resonance imaging | |
AU3359889A (en) | Contrast agents for magnetic resonance imaging | |
EP0412824A3 (en) | Magnetic resonance imaging system | |
GB2275538B (en) | Frustoconical magnet for magnetic resonance imaging | |
EP0443677A3 (en) | Quadrature surface coil construction for magnetic resonance imaging apparatus | |
GB2245364B (en) | Magnetic resonance imaging coil | |
AU8950291A (en) | Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging | |
EP0450949A3 (en) | Actively shielded magnetic resonance magnet without cryogens | |
GB8813425D0 (en) | Magnetic resonance imaging | |
EP0495287A3 (en) | Magnetic resonance imaging | |
GB2240628B (en) | Magnetic resonance imaging apparatus | |
SG49633A1 (en) | Magnetic resonance imaging apparatus | |
EP0453102A3 (en) | Magnetic resonance imaging methods and apparatus | |
GB2234594B (en) | Nuclear magnetic resonance imaging methods | |
IL85785A0 (en) | Quadrature magnetic arrangement surface coil for resonance spectroscopy or imaging system | |
EP0430104A3 (en) | Magnetic resonance imaging apparatus | |
EP0439119A3 (en) | Magnetic resonance imaging system | |
GB9007655D0 (en) | Magnetic resonance imaging technique | |
GB2245992B (en) | Magnetic resonance imaging sequencer gating | |
IL98977A0 (en) | Echo-volumar magnetic resonance imaging using 180grad rf pulses | |
AU7044791A (en) | Transition metal complexes for magnetic resonance diagnosis | |
GB2234595B (en) | Nuclear magnetic resonance imaging methods | |
AU6280794A (en) | High relaxivity, paramagnetic, metal complexes for magnetic resonance imaging | |
GB9107071D0 (en) | Vhf applicator for magnetic resonance imaging |